Schering-Plough Board Elects Dr. Craig B. Thompson as a Director
healthcare company. Through its own biopharmaceutical research and collaborationswith partners Schering-Plough creates therapies that help save and improvelives around the world. The company applies its research-and-developmentplatform to human prescription and consumer products as well as to animalhealth products. In November 2007 Schering-Plough acquired OrganonBioSciences with its Orga
Date:1/3/2008
health
care company. Through its own biopharmaceutical research and collaborations
with partners, Schering-Plough creates therapies that help save and improve
lives around the world. The company applies its research-and-development
platform to human prescription and consumer products as well as to animal
health products. In November 2007, Schering-Plough acquired Organon
BioSciences, with its Organon human health and Intervet animal health
businesses, marking a pivotal step in the company's ongoing transformation.
Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors,
patients, customers and other stakeholders served by its approximately
50,000 people around the world. The company is based in Kenilworth, N.J.,
and its Web site is
http://www.schering-plough.com.
'/>"/>SOURCE Schering-Plough Corporation Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related medicine news :1.
Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab2.
Schering-Plough Declares Quarterly Dividends on Common Shares and 2007 Mandatory Convertible Preferred Stock3.
Schering-Plough Receives Clearance From U.S. Federal Trade Commission for Planned Acquisition of Organon Biosciences N.V.4.
Schering-Plough to Webcast CFO Robert J. Bertolinis Presentation at 2007 Credit Suisse Health Care Conference5.
Schering-Plough Reports U.S. District Court for District of Massachusetts Finds No Liability for Subsidiary in AWP Case6.
Schering-Plough CEO Calls for Four-Pronged Approach to Improving Current Health Care Environment7.
Schering-Plough Reports Financial Results for Third Quarter of 20078.
Schering-Plough Schedules Conference Call and Webcast for 2007 Third Quarter Earnings9.
Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet10.
Louise McCormick Joins Heskas Board of Directors11.
Combined Boards Provide Better Care to More Clients More Efficiently